Biotech

All Articles

After FDA rejection as well as unemployments, Lykos chief executive officer is leaving

.Lykos chief executive officer and also founder Amy Emerson is actually walking out, along with prin...

Novartis stirs up new phase of Voyager contract with $15M capsid package

.Novartis is opening a new outpost in its collaboration along with Voyager Rehabs, spending $15 thou...

Lilly posts extra positive records on its own once a week insulin possibility

.On the heels of an FDA turndown for its own primary competing Novo Nordisk, Eli Lilly is making hea...

IN 8bio halts phase 2 trial, lays off half of labor force

.Simply a couple of months after dosing the initial client in a period 2 trial for freshly diagnosed...

Lilly, Haya ink $1B biobuck obesity contract to browse black genome

.Eli Lilly's look for obesity aim ats has led it to the black genome. The Big Pharma has assembled a...

ArsenalBio raises $325M, pivots far from previous lead asset

.Toolbox Biosciences is moving on up. The cell treatment business has added on $325 million in ammo ...

Lilly- backed weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis use medicine flunks stage 2b, steering Indivior to reassess $100M choice

.Aelis Farma's hopes of protecting a quick, favorable decision on a $one hundred thousand alternativ...

ProKidney stops phase 3 test not needed to have for cell treatment approval

.ProKidney has actually stopped one of a pair of phase 3 tests for its own cell therapy for kidney i...

Vaxcyte surges on 'stunning' 31-valent PCV succeed versus Pfizer

.Vaxcyte introduced what professionals named "remarkable" period 1/2 information for its own 31-vale...